EntreMed (ENMD) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : EntreMed (ENMD)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: DavidCG who wrote (1325)	10/25/1998 11:58:00 AM
From: muddphudd	Read Replies (2) of 2135

I think it will be about 2 years before we see this being used to treat brain tumors. The obstacles will be toxicity and whether they can find to way to keep the gene(s) turned on after they are transfected (often time, the gene is turned on for a short time and then shuts down) Don't get me wrong, I think gene therapy will eventually be worked out. Right now there are many technical problems, ranging from vectors, expression pattern, transfection techniques, and toxicity. My sister is a researcher working in one of the top lab on cystic fibrosis. They have been trying gene therapy for a long time. Lots of obstacles. Then again, no believed Folkman for decades.......

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next